Cellectar Biosciences Inc

NASDAQ CLRB

Data sourced from iex and EODHD
Download Data

Cellectar Biosciences Inc Cash Flow Statement 2005 - 2024

This table shows the Cash Flow Statement for Cellectar Biosciences Inc going from 2005 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31
Net Income
M -51 -38 -38 -32 -31 -29 -27 -25 -24 -24 -22 -20 -17 -15 -15 -15 -14 -14 -15 -14 -13 -13 -13 -14 -14 -14 -12 -11 -10 -6 -3 -2 -2 -5 -9 -8 -7 -8 -9 -10 -10 -11 -9 -10 -10 -9 -9 -8 -9 -7 -6 -5 -4 2 -10 -12 -15 -22 -12 -11 -11 -16 -21 -25 -24 -20 -16 -12 -9 -8 -6 -4 -4 -3 -2 -1 0
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Non-Cash Items (Other)
M 12 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 2 2 0 0 1 1 1 1 1 1 0 0 0 0 1 1 1 1 2 2 2 2 -1 -3 -6 -9 -9 -8 -8 -5 -3 -1 1 -8 1 2 5 12 3 3 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 0 -
Operating Cash Flow
M -39 -32 -30 -29 -27 -25 -22 -22 -23 -23 -22 -19 -15 -14 -13 -13 -12 -12 -12 -11 -11 -11 -12 -11 -11 -11 -11 -10 -9 -8 -7 -7 -8 -8 -9 -9 -9 -9 -9 -10 -10 -9 -8 -7 -7 -7 -6 -6 -6 -6 -5 -5 -5 -8 -9 -10 -10 -11 -11 -13 -16 -17 -19 -19 -16 -13 -11 -9 -8 -6 -5 -3 -3 -2 -2 -1 0
Capital Expenditures
M -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 -1 -1 -1 -1 -1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Acquisitions
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Investing Activities
M - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 4 4 4 2 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Cash Flow
M - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 4 4 4 2 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - -
Repayment/Issuance of Debt (Net)
M - - - - - - - - - - 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 4 4 8 4 4 4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Equity Repurchase (Common, Net)
M 0 0 - - - - - - 0 1 -16 -16 2 1 27 36 27 27 18 24 15 15 16 1 1 4 11 11 19 16 8 8 0 0 0 12 12 12 12 0 0 0 0 0 0 32 64 69 73 42 10 5 - - - - - - - - - - - - - - - - - - - - - - - - -
Dividends Paid
M - - - - - - - - - - - - - - - - - - 2 2 2 2 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 5 5 5 1 3 3 3 4 3 3 3 1 0 1 1 1 1 0 0 0 0 0 0 - - - -
Other Financial Activities
M 1 1 -1 0 0 0 0 0 0 1 2 2 20 19 9 9 0 0 2 17 8 8 18 3 3 6 6 6 14 11 8 7 -1 -1 0 1 1 5 4 6 6 2 3 1 1 1 0 0 4 8 8 10 5 2 4 6 6 8 12 8 8 6 -14 -13 1 1 15 12 -2 -2 -2 -1 2 2 2 3 0
Financing Cash Flow
M 1 1 -1 0 0 0 0 0 0 1 2 2 20 19 9 9 0 0 2 17 8 8 18 3 3 6 6 6 14 11 8 7 -1 -1 0 1 1 5 4 6 6 2 3 1 1 1 0 0 4 8 8 10 5 2 4 6 6 8 12 8 8 6 -14 -13 1 1 15 12 -2 -2 -2 -1 2 2 2 3 0
Exchange Rate Adjustment
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Beginning Cash
M 10 19 5 13 20 18 25 31 36 40 47 54 57 19 22 7 11 13 17 10 13 16 4 7 10 6 8 11 11 6 8 2 4 2 5 7 9 12 2 4 2 5 6 8 5 6 7 4 6 2 3 1 3 3 3 6 9 6 4 7 1 4 6 7 10 15 19 8 10 12 16 17 4 5 2 0 0
Ending Cash
M 40 10 19 5 13 20 18 25 31 36 40 47 54 57 19 22 7 11 13 17 10 13 16 4 7 10 6 8 11 11 6 8 2 4 2 5 7 9 12 2 4 2 5 6 8 5 6 7 4 6 2 3 2 2 3 3 6 9 6 4 7 1 4 6 7 10 15 19 8 10 12 16 17 4 5 2 0
Stock-Based Compensation
M 2 2 2 2 2 1 1 2 1 1 1 1 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 1 1 1 1 2 2 2 2 1 1 2 2 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 -
Issuance/Purchase of Shares
M 0 0 - - - - - - 0 1 -16 -16 2 1 27 36 27 27 18 24 15 15 16 1 1 4 11 11 19 16 8 8 0 0 0 12 12 12 12 0 0 0 0 0 0 32 64 69 73 42 10 5 - - - - - - - - - - - - - - - - - - - - - - - - -
Capital Stock Change
M 0 0 10 10 10 10 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Working Capital
M 25 7 25 33 54 74 91 117 141 164 186 163 139 95 49 45 41 45 49 51 38 35 32 22 27 32 34 34 33 21 9 2 -5 -3 6 18 17 15 6 -3 -1 1 7 11 18 20 21 17 13 11 8 3 -2 -3 -13 -12 -13 -11 -8 -9 -8 -13 -4 9 29 41 47 50 48 57 51 43 28 11 6 1 0
Free Cash Flow
M -39 -33 -31 -29 -28 -25 -23 -22 -23 -23 -22 -19 -15 -14 -13 -13 -12 -12 -12 -12 -11 -12 -12 -11 -11 -11 -11 -11 -10 -8 -7 -7 -8 -8 -9 -9 -9 -9 -9 -10 -10 -9 -8 -7 -7 -7 -6 -6 -6 -6 -5 -5 -5 -8 -9 -10 -10 -11 -11 -13 -17 -17 -19 -19 -16 -13 -11 -9 -8 -6 -5 -3 -3 -2 -2 -1 0

StockViz Staff

September 20, 2024

Any question? Send us an email